Kim Kelderman Power - 01 Jun 2026 Form 4 Insider Report for CONMED Corp (CNMD)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Jun 2026, 16:17:00 UTC
Prior SEC filing
07 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Thomas Fistek for Kim Kelderman by Power of Attorney

Key filing fact

Kim Kelderman Power filed Form 4 for CONMED Corp (CNMD) on 03 Jun 2026.

Key facts

  • This page summarizes Kim Kelderman Power's Form 4 filing for CONMED Corp (CNMD).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 03 Jun 2026, 16:17.

Change

  • Previous filing in this sequence was filed on 07 May 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001739054 Primary reporting owner

Kelderman Kim

Relationship
Director
Address
C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO
Signature
/s/ Thomas Fistek for Kim Kelderman by Power of Attorney
Signature date
03 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CNMD transaction Derivative

RSUs (Restricted Stock Units)

Award

Transaction value
Shares
+5,772
Change %
Price
$0.000000*
Shares after
5,772
Date
01 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,772
Exercise price
$0.000000
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .